Cargando…
Future Research Priorities for Morbidity Control of Lymphedema
BACKGROUND: Innovation in the treatment of lower extremity lymphedema has received low priority from the governments and pharmaceutical industry. Advancing lymphedema is irreversible and initiates fibrosis in the dermis, reactive changes in the epidermis and subcutis. Most medical treatments offered...
Autores principales: | Narahari, S R, Aggithaya, Madhur Guruprasad, Moffatt, Christine, Ryan, T J, Keeley, Vaughan, Vijaya, B, Rajendran, P, Karalam, S B, Rajagopala, S, Kumar, N K, Bose, K S, Sushma, K V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286751/ https://www.ncbi.nlm.nih.gov/pubmed/28216723 http://dx.doi.org/10.4103/0019-5154.198039 |
Ejemplares similares
-
Yoga protocol for treatment of breast cancer-related lymphedema
por: Narahari, SR, et al.
Publicado: (2016) -
Response to comment on the article, “Yoga protocol for treatment of breast cancer-related lymphedema”
por: Narahari, SR, et al.
Publicado: (2017) -
Yoga for correction of lymphedema's impairment of gait as an adjunct to lymphatic drainage: A pilot observational study
por: Aggithaya, Madhur Guruprasad, et al.
Publicado: (2015) -
A protocol for systematic reviews of Ayurveda treatments
por: Narahari, Saravu R, et al.
Publicado: (2010) -
Literature searches on Ayurveda: An update
por: Aggithaya, Madhur G., et al.
Publicado: (2015)